Company cofounder to sermon usage of artificial quality and instrumentality learning applications for precision medicine successful neurology

, /PRNewswire/ -- Beacon Biosignals CEO and co-founder Jacob Donoghue, MD, Ph.D., volition beryllium speaking astatine the Precision Medicine World Conference (PMWC) 2023 being held successful Silicon Valley from Jan. 25-27, the institution announced today.

The PMWC is the foremost precision medicine conference, bringing unneurotic much than 2,500 recognized leaders, apical planetary researchers, aesculapian professionals and innovators successful an effort to accelerate the improvement and dispersed of precision medicine. It provides a forum for the speech of accusation astir the latest advances successful technology, objective implementation, research, and successful each aspects related to the regulatory and reimbursement sectors.

Dr. Donoghue volition beryllium portion of a sheet league titled "AI/ML Applications for Patient Outcomes Prediction and Clinical Support" connected Friday, Jan. 27, from 1 to 2 p.m. astatine the Santa Clara Convention Center successful Santa Clara, Calif. This league is portion of Track 2 (AI & Data Sciences successful Drug Discovery & Clinical Research) connected Day 3 of the yearly conference.

The sheet volition beryllium moderated by Alex Sherman, a main subordinate successful Neurology astatine Harvard Medical School and manager of the Center for Innovation and Bioinformatics astatine the Neurological Clinical Research Institute astatine Massachusetts General Hospital (MGH). In summation to Dr. Donoghue, confirmed panelists include:

  • Indu Navar, EverythingALS
  • Nuray Yurt, Novartis Oncology
  • Marie Abele Bind, MGH/Harvard Medical School

Dr. Donoghue completed his aesculapian grade from the Health Sciences & Technology programme astatine Harvard Medical School and his Ph.D. successful neuroscience from MIT, wherever his probe focused connected computational neurophysiology and the effects of neuroactive compounds connected encephalon web activity. He co-founded Beacon Biosignals successful 2019.

Dr. Donoghue volition sermon Beacon's advancement utilizing instrumentality learning to analyse epileptiform load and slumber endpoints derived from electroencephalogram (EEG) recordings. Stratifying patients based connected these insights provides a much elaborate knowing of a patient's condition, and tin pb to much targeted and effectual attraction plans.

The world's starring computational neurodiagnostics company, Beacon harnesses instrumentality learning that unlocks the powerfulness of EEG information to beforehand precision medicines for neurologic and psychiatric disorders.

About Beacon Biosignals             
Beacon's instrumentality learning level for EEG enables and accelerates caller treatments that alteration the lives of patients with neurological, psychiatric oregon slumber disorders. Through caller instrumentality learning algorithms, ample objective datasets, and advances successful bundle engineering, Beacon Biosignals empowers biopharma companies with unparalleled tools for efficacy monitoring, diligent stratification, and objective proceedings endpoints from encephalon data. For much information, sojourn https://beacon.bio/. For careers, sojourn https://beacon.bio/careers; for concern inquiries, sojourn https://beacon.bio/contact. Follow america connected Twitter (@Biosignals) oregon LinkedIn (https://www.linkedin.com/company/beacon-biosignals).

MEDIA CONTACT
Megan Moriarty
Amendola Communications for Beacon Biosignals
913.515.7530
[email protected]

SOURCE Beacon Biosignals